Clinical implications of a slight increase in the gene dosage of MYCN in neuroblastoma determined using quantitative PCR
Authors:
- 23 August 2008
- journal article
- research article
- Published by Springer Nature in Pediatric Surgery International
- Vol. 24 (10) , 1095-1100
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Use of Chromogenic In Situ Hybridization to Identify MYCN Gene Copy Number in Neuroblastoma Using Routine Tissue SectionsAmerican Journal of Surgical Pathology, 2006
- Prediction of MYCN Amplification in Neuroblastoma Using Serum DNA and Real-Time Quantitative Polymerase Chain ReactionJournal of Clinical Oncology, 2005
- Assessment of NMYC amplification: a comparison of FISH, quantitative PCR monoplexing and traditional blotting methods used with formalin-fixed, paraffin-embedded neuroblastomas.2005
- MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplificationEuropean Journal of Cancer, 2004
- Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastomaJournal of Pediatric Surgery, 2004
- Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines*†Medical and Pediatric Oncology, 2001
- Biology and Genetics of Human NeuroblastomasJournal of Pediatric Hematology/Oncology, 1997
- Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomasNucleic Acids Research, 1994
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984